Anastrozole 1 mg provides a cost-effective survival benefit, compared with megestrol acetate, for patients treated for advanced breast cancer

E Thompson, M Drummond, A Howell, W Jonat, J Brown

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)OP27-OP27
Number of pages1
JournalEuropean Journal of Cancer
Publication statusPublished - Nov 1997

Cite this